An Open-lable, Multicenter, expanded access study of INC424 for patients with primary myelofibrosis (PMF) or post polycythemia myelofibrosis (PPV MF) or post-essential thrombocythemia myelofibrosis (PET-MF).
2022-06-29
عنوان الدراسة
An Open-lable, Multicenter, expanded access study of INC424 for patients with primary myelofibrosis (PMF) or post polycythemia myelofibrosis (PPV MF) or post-essential thrombocythemia myelofibrosis (PET-MF).
داعم الدراسة
Novartis
دواء الدراسة
INC424 (ruxolitinib)
رقم بروتوكول الدراسة
CINC424A2401
حالة الدراسة
Completed
موقع الدراسة
NGHA-R
مرحلة الدراسة
3b
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.